Donor Login
Contact Us
Breakthrough T1D

About
Investment Strategy
Portfolio
Our Team
Venture Philanthropy
News
Donor Login
Get in Touch

News and Press

eGenesis Announces $100 Million Series B Financing

CAMBRIDGE, Mass. – November 07, 2019

About The T1D Fund

The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D. Launched in December 2016, our aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D. It’s the first scaled, mission-driven venture philanthropy fund focused on equity investments in partnership with additional sources of capital, including venture capital, corporations, and foundations. By investing in areas strategically aligned with Breakthrough T1D (formerly JDRF), the leading global T1D research and advocacy organization, we can exclusively focus on supporting innovative approaches and novel mechanisms with curative potential. We are a mission-driven organization that continues to support companies that play a role in the discovery and therapeutic development of effective solutions to T1D.

About
Investment
Strategy
Portfolio
Our People
Venture
Philanthropy
News
Privacy Policy

Contact Us

For more information email us at info@t1dfund.org

© Copyright 2024. All Rights Reserved